About us

Our goal

In order to accelerate the development of new drugs for treating vasculardiseases at low cost, nonclinical and clinical trials have been successfully completed and developed as a new global blockbuster drug.

It aims to develop a successful exit strategy through the establishment and operation of Bio-SPC to develop new medicines for various angiotherapy through expansion of the adaptation.

Successful bio R&D projects that facilitate the creation of a virtuous cycle of reinvestment or payback.